Mankind Pharma Ltd |
|
|
| Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of (Rs)1,080 per equity share ("Offer Price") aggregating to (Rs)4326.36 crores, comprising an offer for sale of 3,705,443 equity shares aggregating to (Rs)400.18 crores by Ramesh Juneja, 3,505,149 equity shares aggregating to (Rs)378.56 crores by Rajeev Juneja, 2,804,119 equity shares aggregating to (Rs)302.85 crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), 17,405,559 equity shares aggregating to (Rs)1879.80 crores by Cairnhill Cipef Limited, 2,623,863 equity shares aggregating to (Rs)283.38 crores by Cairnhill CGPE Limited, 9,964,711 equity shares aggregating to (Rs)1076.19 crores by Beige Limited and 50,000 equity shares aggregating to (Rs)5.40 crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute 10% of the post-offer paid-up equity share capital of the company.
|
| Issue |
Money Payable On |
| Opened On |
Closed On |
Offer Price |
Application Money |
Allotment Money |
| 25-Apr-23 |
27-Apr-23 |
( )1,080.00 |
( )1,080.00 |
( )0.00 |
| Minimum Application for shares in Nos :13 Further Multiples of :13 |
| |
( Cr) |
Lead Managers to the Issue |
| Project Cost |
0.00 |
| Axis Capital Ltd | | IIFL Securities Ltd | | J.P.Morgan India Pvt Ltd | | Jefferies India Pvt Ltd | | Kotak Mahindra Capital Company Ltd |
|
| Project Financed through Current Offer |
4326.36 |
|
| Post Issue Equity Share Capital |
40.06 |
|
| Face Value |
1 |
|
| Issue Price |
( )1080.00 |
|
|